Second Quarter 2025 Results Key Financial Results Revenue: US$1.29b (up 11% from 2Q ...

Full Year 2025 Results Key Financial Results Revenue: US$81.4b (up 3.2% from FY 2024). Net ...

The key change was the execution and completion of 145 store closures, which moved from planning in Q4 2025 to full implementation in Q1 2026. Management shifted from assessment and planning to ...

Q2 2025 Management View President and CEO Peter J. Arduini reported continued business execution, healthy customer demand, ...

Teva Pharmaceuticals reports strong Q2 2025 growth from innovative drugs like AUSTEDO and AJOVY, raises guidance, and reaffirms confidence in 2027 ...

Q2 2025 Management View President and CEO Scott E. Huckins stated that "we delivered another solid quarter in line with our ...

EPS condemned the DMK government and held it responsible for rising crimes rooted in caste-based violence and honour killings across Tamil Nadu. In a post on X, EPS said, "Under the Stalin-led Failure ...

Operating margin improved to 17.6% in Q2 2025, with standout performance driven by growth in digital solutions and margin expansion in high-value segments. These 10 stocks could mint the next wave of ...

This article breaks down a key moment from The Gilded Age Season 3, Episode 6. Proceed at your own risk. Oscar van Rhijn will ...

Management reaffirmed full-year guidance for 2025 despite soft revenue and challenges in excess investment income. These 10 stocks could mint the next wave of millionaires › Globe Life (NYSE:GL), a ...

UnitedHealth Group ( NYSE: UNH) reported stronger-than-expected earnings for the second quarter of 2025, with adjusted ...

Blackbaud boosted its forecast for 2025 adjusted earnings to $4.30-to-$4.50 a share from a previous estimate of $4.16-to-$4.35 a share. Blackbaud now anticipates revenue of $1.12 billion to $1.13 ...